Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate. - Wikidata - awgldk - TriplyDB

Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

http://www.wikidata.org/entity/Q37643724

about

Vaccine platforms to control Lassa fever.Understanding the cryptic nature of Lassa fever in West Africa.Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.

P2860

Q38823264-A89B48A1-0D16-465C-B5FE-E979C8046B4F Q40040547-7BBFD7C7-725E-416B-95CB-016463CC1003 Q40156113-34F7D618-8714-4425-96DB-2FB2E4A59145

P2860

Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

http://www.wikidata.org/entity/Q37643724

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

@en

Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

@nl

type

label

Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

@en

Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

@nl

prefLabel

Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

@en

Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

@nl

P1433

Q37643724-B5F16DDF-4554-46EF-AB01-A4E79394C96E

P1476

Q37643724-5EAD3EC6-7530-499A-9AE8-5EC2E5FDE7F4

P2093

Q37643724-055CC806-03D2-408D-80E5-D2CCB6AB94A9

Q37643724-0CD1FDED-0079-4E41-BAE9-06CB73127337

Q37643724-1E6B9EB9-4047-4493-9F0C-0CD8EC9AE729

Q37643724-41E3C7F8-68A2-4D99-8AE1-930025040045

Q37643724-7EB4E908-B520-4096-BAE1-CD07ACD698BF

Q37643724-82EF431F-45CC-4E66-B66D-593926C6EA95

Q37643724-98FB9757-436E-4273-855A-C0F165AD2C7E

Q37643724-D77F0507-EFF0-4B94-AE35-BCBCBA436165

Q37643724-D9E8114D-5812-46AC-91CB-5D60D9F844D0

P2860

Q37643724-00FFFE95-6A76-41C3-ABD6-C5B37B017DC4

Q37643724-08EF6F70-EA2F-40F4-B2CD-1D0FFFD86C4F

Q37643724-0EFF2A3D-2AE1-4988-BCE3-A5583A7D4D99

Q37643724-13725AFB-46D7-484B-8FA3-B9D75B2B058A

Q37643724-1AEC0437-5FF1-4B47-87AF-E98EC3DEE68A

Q37643724-1BDEF06A-A184-40D9-B7DC-2BEE50754D25

Q37643724-269A026A-2965-405F-ABED-37736B5A949B

Q37643724-2BAB41CC-916C-44B7-910C-3F7F52049988

Q37643724-2F66600E-45F7-4B18-A050-43D9F2F20E39

Q37643724-31B63381-A956-470F-AACF-DA54823E76FB

P304

Q37643724-C1C981E0-3200-447E-B3EE-D96905AD3ADC

P31

Q37643724-BAE5CCFF-99E2-48FF-84DC-14BFD48D79CE

P356

Q37643724-77587689-0085-42B2-A409-562958D18F7D

P407

Q37643724-D0DA63EF-3D30-4734-B5D7-33A04A81970D

P433

Q37643724-4686D8E0-EB46-4CF8-8B91-0F5DBB2C9475

P478

Q37643724-312776DC-EDFE-436B-9BB9-D2C5977C80C3

P50

Q37643724-0E0C8E16-F917-4825-A6EC-B407A26BFB9C

Q37643724-2ADAE611-EC07-4898-B83C-179AFABB44DA

Q37643724-75D833E5-4C24-4581-B0DA-52E82807C05E

Q37643724-F161E0A6-56E9-41DA-B405-D884F761A19A

P577

Q37643724-DC19533B-B623-4B6E-B78E-6E5A22683FB5

P698

Q37643724-A6D9CF7A-EBDA-4034-A94E-3A8B4F1E8603

P921

Q37643724-0A138376-2508-4673-9CAE-A3B6B5FED4B4

Q37643724-C76F39D2-B113-4D2F-A4AA-EAE3B8D18B65

P932

Q37643724-3A483FE9-944F-455D-8ED3-ECF71248DCCB

P356

P1433

Journal of Virology

P1476

Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

@en

P2093

Igor S Lukashevich

http://www.w3.org/2001/XMLSchema#string

Lindsay M Eyzaguirre

http://www.w3.org/2001/XMLSchema#string

Lisa Sadzewicz

http://www.w3.org/2001/XMLSchema#string

Luke J Tallon

http://www.w3.org/2001/XMLSchema#string

Mahmoud Djavani

http://www.w3.org/2001/XMLSchema#string

Marco Goicochea

http://www.w3.org/2001/XMLSchema#string

Maria S Salvato

http://www.w3.org/2001/XMLSchema#string

Qi Su

http://www.w3.org/2001/XMLSchema#string

Yuka Nadai

http://www.w3.org/2001/XMLSchema#string

P2860

RNA virus error catastrophe: direct molecular test by using ribavirin

Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice

Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver

Efficient Virus Extinction by Combinations of a Mutagen and Antiviral Inhibitors

Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo

Patterns of Intra- and Interhost Nonsynonymous Variation Reveal Strong Purifying Selection in Dengue Virus

Cap binding and immune evasion revealed by Lassa nucleoprotein structure

Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression

Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population

Codon usage bias and the evolution of influenza A viruses. Codon Usage Biases of Influenza Virus

P304

3058-3066

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.03035-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Claire M. Fraser

P577

2013-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24335292

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine

P932

3957910

http://www.w3.org/2001/XMLSchema#string